Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
HK Stock MarketDetailed Quotes
TATA HEALTH (01255)
- 1.950
- +0.050+2.63%
Trading May 6 13:54 CST
473.55MMarket Cap35.45P/E (TTM)
1.950High1.900Low18.00KVolume1.900Open1.900Prev Close34.90KTurnover0.01%Turnover Ratio35.45P/E (Static)242.85MShares2.65052wk High-8.71P/B473.55MFloat Cap0.88052wk Low--Dividend TTM242.85MShs Float13.900Historical High--Dividend LFY2.63%Range %0.190Historical Low1.939Avg Price2000Lot Size--Div Yield TTM--Div Yield LFY
TATA HEALTH (01255) Cash Flow
All
YOY
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 120.56%13.99M | ---- | -92.07%-68.03M | ---- | -1,518.50%-35.42M | ---- | 103.61%2.5M | ---- | 59.96%-69.14M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 89.97%-293K | ---- | -19.46%-2.92M | ---- | -69.27%-2.45M | ---- | -21.53%-1.45M | ---- | -111.19%-1.19M | ---- |
| Interest expense - adjustment | -34.13%2.8M | ---- | 146.40%4.25M | ---- | -30.87%1.72M | ---- | -9.54%2.49M | ---- | -22.77%2.76M | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | 2,544.76%5.55M | ---- | -47.50%210K | ---- | -30.19%400K | ---- | 173.46%573K | ---- |
| Impairment and provisions: | -99.48%106K | ---- | 403.39%20.41M | ---- | 69.46%-6.73M | ---- | -775.25%-22.02M | ---- | -96.79%3.26M | ---- |
| -Impairmen of inventory (reversal) | 38.37%-3.9M | ---- | 64.86%-6.32M | ---- | 23.38%-17.99M | ---- | -264.02%-23.47M | ---- | -110.21%-6.45M | ---- |
| -Other impairments and provisions | -85.03%4M | ---- | 137.37%26.73M | ---- | 675.41%11.26M | ---- | -85.04%1.45M | ---- | -74.81%9.71M | ---- |
| Revaluation surplus: | --700K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---200K | ---- |
| -Fair value of investment properties (increase) | --700K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---200K | ---- |
| Asset sale loss (gain): | ---40.1M | ---- | ---- | ---- | 99.59%-134K | ---- | -9,263.35%-32.96M | ---- | 85.80%-352K | ---- |
| -Loss (gain) from sale of subsidiary company | ---40.1M | ---- | ---- | ---- | ---210K | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | 100.23%76K | ---- | -9,263.35%-32.96M | ---- | 33.96%-352K | ---- |
| Depreciation and amortization: | -25.67%11.55M | ---- | 9.75%15.54M | ---- | 17.82%14.16M | ---- | -12.69%12.02M | ---- | -43.63%13.76M | ---- |
| Special items | -3,844.21%-3.56M | ---- | 121.94%95K | ---- | 62.28%-433K | ---- | -103.19%-1.15M | ---- | 26.43%-565K | ---- |
| Operating profit before the change of operating capital | 41.01%-14.81M | ---- | 13.61%-25.11M | ---- | 27.63%-29.07M | ---- | 21.39%-40.16M | ---- | -7.39%-51.1M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -42.00%5.15M | ---- | -65.66%8.87M | ---- | 18.13%25.84M | ---- | -34.94%21.87M | ---- | 56.92%33.62M | ---- |
| Accounts receivable (increase)decrease | -113.17%-18.82M | ---- | -1,086.56%-8.83M | ---- | -111.90%-744K | ---- | 154.51%6.25M | ---- | -170.86%-11.47M | ---- |
| Accounts payable increase (decrease) | -58.07%11.44M | ---- | -34.50%27.29M | ---- | 77.51%41.66M | ---- | -2.41%23.47M | ---- | 140.33%24.05M | ---- |
| Special items for working capital changes | 109.70%59K | ---- | -714.14%-608K | ---- | --99K | ---- | ---- | ---- | ---- | ---- |
| Adjustment items for working capital changes | ---- | ---- | ---200K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from business operations | -1,302.05%-16.99M | ---- | -96.26%1.41M | ---- | 230.55%37.79M | ---- | 333.40%11.43M | ---- | -2,020.78%-4.9M | ---- |
| Other taxs | ---- | ---- | ---178K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of business | ---- | -397.41%-14.11M | ---- | 133.78%4.74M | ---- | -2,891.65%-14.04M | 78,550.00%1.57M | 142.02%503K | --2K | -115.68%-1.2M |
| Net cash from operations | -1,475.30%-16.99M | -397.41%-14.11M | -96.73%1.24M | 133.78%4.74M | 190.57%37.79M | -2,891.65%-14.04M | 365.63%13.01M | 142.02%503K | -2,020.00%-4.9M | -115.68%-1.2M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -82.98%256K | -63.83%331K | 37.73%1.5M | 47.58%915K | 250.00%1.09M | 612.64%620K | 14.29%312K | -65.75%87K | -7.46%273K | 14.41%254K |
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---5.03M |
| Loan receivable (increase) decrease | ---- | 93.46%-169K | ---- | ---2.59M | -121.64%-1.33M | ---- | 115.79%6.15M | --4.14M | -10,478.67%-38.92M | ---- |
| Decrease in deposits (increase) | 2,625.49%22.1M | --22.1M | -27.92%-875K | ---- | -176.92%-684K | -14,447.73%-6.4M | -1,200.00%-247K | -193.33%-44K | 99.91%-19K | 99.93%-15K |
| Sale of fixed assets | ---- | ---- | --25K | ---- | ---- | ---- | -70.73%1M | 187.36%1M | 469.33%3.42M | --348K |
| Purchase of fixed assets | 20.57%-3.81M | ---- | -20.06%-4.79M | ---- | -350.68%-3.99M | 91.08%-96K | 17.89%-886K | 86.02%-1.08M | 65.02%-1.08M | -302.35%-7.7M |
| Sale of subsidiaries | ---1.58M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---4.63M | ---- |
| Recovery of cash from investments | -45.47%2.82M | ---- | 74.12%5.17M | ---- | -1.49%2.97M | ---- | -19.32%3.02M | ---- | -19.72%3.74M | --150K |
| Cash on investment | -41.07%-4.41M | ---- | 49.84%-3.12M | ---- | -341.08%-6.23M | ---- | 45.46%-1.41M | ---- | -79.54%-2.59M | ---- |
| Other items in the investment business | ---- | ---- | ---5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 833.73%15.38M | 1,432.14%22.26M | 74.35%-2.1M | 71.57%-1.67M | -203.08%-8.17M | -242.96%-5.88M | 119.91%7.93M | 134.30%4.11M | -109.95%-39.81M | 45.29%-11.99M |
| Net cash before financing | -86.53%-1.61M | 165.25%8.15M | -102.91%-861K | 115.43%3.07M | 41.48%29.62M | -531.71%-19.92M | 146.82%20.93M | 135.00%4.61M | -138.98%-44.71M | 7.64%-13.18M |
| Cash flow from financing activities | ||||||||||
| New borrowing | --15.03M | ---- | ---- | ---- | -131.27%-3.09M | 1,208.95%10.28M | -59.13%9.87M | -106.17%-927K | -69.62%24.16M | -57.23%15.03M |
| Refund | -122.89%-331K | ---- | 128.92%1.45M | ---- | 53.30%-5M | ---- | 71.30%-10.71M | ---- | 42.77%-37.31M | -248.60%-63.4M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --74.5M | --74.5M |
| Interest paid - financing | -2.42%-1.86M | -73.35%-1.26M | -15.29%-1.82M | -54.56%-728K | -40.84%-1.58M | -18.64%-471K | -31.18%-1.12M | 16.24%-397K | 50.41%-853K | 58.42%-474K |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -97.17%226K |
| Net cash from financing operations | 77.88%-3.47M | -75.00%-8.75M | 31.24%-15.7M | -245.46%-5M | -63.48%-22.83M | 145.65%3.44M | -132.30%-13.97M | -133.95%-7.53M | 360,241.67%43.24M | 1,482.18%22.18M |
| Effect of rate | ---- | ---- | ---- | ---- | -598.39%-433K | 42.71%705K | -1,650.00%-62K | 180.46%494K | -95.29%4K | -2,458.33%-614K |
| Net Cash | 69.33%-5.08M | 68.83%-601K | -344.03%-16.56M | 88.30%-1.93M | -2.61%6.79M | -465.00%-16.48M | 574.34%6.97M | -132.41%-2.92M | 92.14%-1.47M | 156.68%9M |
| Begining period cash | -42.51%23M | -42.51%23M | 18.88%40M | 18.88%40M | 25.82%33.65M | 25.82%33.65M | -5.19%26.74M | -5.19%26.74M | -39.75%28.21M | -39.75%28.21M |
| Cash at the end | -23.56%17.92M | -41.17%22.4M | -41.40%23.44M | 113.03%38.07M | 18.88%40M | -26.51%17.87M | 25.82%33.65M | -33.54%24.32M | -5.19%26.74M | 18.37%36.6M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | -22.08%17.92M | ---- | -42.51%23M | ---- | --40M | ---- | ---- | ---- | ---- | ---- |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Auditor | -- | -- | -- | -- | -- | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"